Gilead Sciences
GILD
#134
Rank
C$222.22 B
Marketcap
C$178.99
Share price
2.85%
Change (1 day)
18.97%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): C$9.50

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is C$9.59. In 2024 the company made an earnings per share (EPS) of C$0.53 a decrease over its 2023 EPS that were of C$6.37.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$9.501685.03%
2024C$0.53-91.65%
2023C$6.3723.98%
2022C$5.14-25.86%
2021C$6.934850%
2020C$0.14-97.64%
2019C$5.940.9%
2018C$5.8818.71%
2017C$4.96-64.88%
2016C$14.11-18.45%
2015C$17.3055.28%
2014C$11.14296.02%
2013C$2.8117.89%
2012C$2.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.23 27.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$1.83-80.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$2.88-69.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$39.52 312.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$20.27 111.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$13.09 36.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$7.74-19.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$23.82 148.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$4.98-48.07%๐Ÿ‡บ๐Ÿ‡ธ USA